UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004514 |
|---|---|
| Receipt number | R000005397 |
| Scientific Title | A phase II study of PAD therapy (bortezomib, doxorubicin, and dexamethasone) for relapsed or refractory multiple myeloma. |
| Date of disclosure of the study information | 2010/11/09 |
| Last modified on | 2014/02/24 10:00:31 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/11/08 12:55:08 | ||
| 2 | Update | 2012/09/10 10:37:26 | Recruitment status |
|
| 3 | Update | 2014/02/24 10:00:31 | Email Last name of contact person Last name of contact person Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
